Epigenetic Regulation of Neutrophils in ARDS

Acute respiratory distress syndrome (ARDS) is an inflammatory pulmonary condition that remains at alarming rates of fatality, with neutrophils playing a vital role in its pathogenesis. Beyond their classical antimicrobial functions, neutrophils contribute to pulmonary injury via the release of react...

Full description

Saved in:
Bibliographic Details
Main Authors: Jordan E. Williams, Zannatul Mauya, Virginia Walkup, Shaquria Adderley, Colin Evans, Kiesha Wilson
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/15/1151
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849407454357487616
author Jordan E. Williams
Zannatul Mauya
Virginia Walkup
Shaquria Adderley
Colin Evans
Kiesha Wilson
author_facet Jordan E. Williams
Zannatul Mauya
Virginia Walkup
Shaquria Adderley
Colin Evans
Kiesha Wilson
author_sort Jordan E. Williams
collection DOAJ
description Acute respiratory distress syndrome (ARDS) is an inflammatory pulmonary condition that remains at alarming rates of fatality, with neutrophils playing a vital role in its pathogenesis. Beyond their classical antimicrobial functions, neutrophils contribute to pulmonary injury via the release of reactive oxygen species, proteolytic enzymes, and neutrophil extracellular traps (NETs). To identify targets for treatment, it was found that epigenetic mechanisms, including histone modifications, hypomethylation, hypermethylation, and non-coding RNAs, regulate neutrophil phenotypic plasticity, survival, and inflammatory potential. It has been identified that neutrophils in ARDS patients exhibit abnormal methylation patterns and are associated with altered gene expression and prolonged neutrophil activation, thereby contributing to sustained inflammation. Histone citrullination, particularly via PAD4, facilitates NETosis, while histone acetylation status modulates chromatin accessibility and inflammatory gene expression. MicroRNAs have also been shown to regulate neutrophil activity, with miR-223 and miR-146a potentially being biomarkers and therapeutic targets. Neutrophil heterogeneity, as evidenced by distinct subsets such as low-density neutrophils (LDNs), varies across ARDS etiologies, including COVID-19. Single-cell RNA sequencing analyses, including the use of trajectory analysis, have revealed transcriptionally distinct neutrophil clusters with differential activation states. These studies support the use of epigenetic inhibitors, including PAD4, HDAC, and DNMT modulators, in therapeutic intervention. While the field has been enlightened with new findings, challenges in translational application remain an issue due to species differences, lack of stratification tools, and heterogeneity in ARDS presentation. This review describes how targeting neutrophil epigenetic regulators could help regulate hyperinflammation, making epigenetic modulation a promising area for precision therapeutics in ARDS.
format Article
id doaj-art-942bfa3ff7624387b4d1be0bd3da40ed
institution Kabale University
issn 2073-4409
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-942bfa3ff7624387b4d1be0bd3da40ed2025-08-20T03:36:03ZengMDPI AGCells2073-44092025-07-011415115110.3390/cells14151151Epigenetic Regulation of Neutrophils in ARDSJordan E. Williams0Zannatul Mauya1Virginia Walkup2Shaquria Adderley3Colin Evans4Kiesha Wilson5Department of Pathology, Microbiology & Immunology, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology & Immunology, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology & Immunology, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Cell Biology & Anatomy, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology & Immunology, University of South Carolina School of Medicine, Columbia, SC 29209, USAAcute respiratory distress syndrome (ARDS) is an inflammatory pulmonary condition that remains at alarming rates of fatality, with neutrophils playing a vital role in its pathogenesis. Beyond their classical antimicrobial functions, neutrophils contribute to pulmonary injury via the release of reactive oxygen species, proteolytic enzymes, and neutrophil extracellular traps (NETs). To identify targets for treatment, it was found that epigenetic mechanisms, including histone modifications, hypomethylation, hypermethylation, and non-coding RNAs, regulate neutrophil phenotypic plasticity, survival, and inflammatory potential. It has been identified that neutrophils in ARDS patients exhibit abnormal methylation patterns and are associated with altered gene expression and prolonged neutrophil activation, thereby contributing to sustained inflammation. Histone citrullination, particularly via PAD4, facilitates NETosis, while histone acetylation status modulates chromatin accessibility and inflammatory gene expression. MicroRNAs have also been shown to regulate neutrophil activity, with miR-223 and miR-146a potentially being biomarkers and therapeutic targets. Neutrophil heterogeneity, as evidenced by distinct subsets such as low-density neutrophils (LDNs), varies across ARDS etiologies, including COVID-19. Single-cell RNA sequencing analyses, including the use of trajectory analysis, have revealed transcriptionally distinct neutrophil clusters with differential activation states. These studies support the use of epigenetic inhibitors, including PAD4, HDAC, and DNMT modulators, in therapeutic intervention. While the field has been enlightened with new findings, challenges in translational application remain an issue due to species differences, lack of stratification tools, and heterogeneity in ARDS presentation. This review describes how targeting neutrophil epigenetic regulators could help regulate hyperinflammation, making epigenetic modulation a promising area for precision therapeutics in ARDS.https://www.mdpi.com/2073-4409/14/15/1151ARDSneutrophilsepigeneticslncRNAmiRNAhistone modification
spellingShingle Jordan E. Williams
Zannatul Mauya
Virginia Walkup
Shaquria Adderley
Colin Evans
Kiesha Wilson
Epigenetic Regulation of Neutrophils in ARDS
Cells
ARDS
neutrophils
epigenetics
lncRNA
miRNA
histone modification
title Epigenetic Regulation of Neutrophils in ARDS
title_full Epigenetic Regulation of Neutrophils in ARDS
title_fullStr Epigenetic Regulation of Neutrophils in ARDS
title_full_unstemmed Epigenetic Regulation of Neutrophils in ARDS
title_short Epigenetic Regulation of Neutrophils in ARDS
title_sort epigenetic regulation of neutrophils in ards
topic ARDS
neutrophils
epigenetics
lncRNA
miRNA
histone modification
url https://www.mdpi.com/2073-4409/14/15/1151
work_keys_str_mv AT jordanewilliams epigeneticregulationofneutrophilsinards
AT zannatulmauya epigeneticregulationofneutrophilsinards
AT virginiawalkup epigeneticregulationofneutrophilsinards
AT shaquriaadderley epigeneticregulationofneutrophilsinards
AT colinevans epigeneticregulationofneutrophilsinards
AT kieshawilson epigeneticregulationofneutrophilsinards